INEYE THERAPEUTICS S.A.
PrivateLast Round
VC Round
Jul 2, 2025
Total Funding Raised
$190,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
INEYE THERAPEUTICS S.A. operates in Healthcare & Life Sciences and is based in Coimbra. Its latest recorded funding round was a VC Round in July 2025.
INEYE THERAPEUTICS S.A. is a biotechnology company developing a patented ocular drug delivery technology for the treatment of eye diseases such as dry eye syndrome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
INEYE THERAPEUTICS S.A. Comparables
Compare INEYE THERAPEUTICS S.A. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mati Therapeutics | 85% | |
| Amorphex Therapeutics | 83% | |
| PolyActiva | 79% |
For institutional investors. Book with your work email.
INEYE THERAPEUTICS S.A. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 2, 2025 | ||||
| Grant | Mar 20, 2025 | ||||
| Seed | Sep 18, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
INEYE THERAPEUTICS S.A. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Insight Venture – Sociedade de Capital de Risco, S.A. | VC Round |
| Women TechEU | Grant |
| Portugal Ventures | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 62% MoM.
- Mar 5, 2026
Monthly visitors grew 7117% MoM, from 6 to 433.
For institutional investors. Book with your work email.
INEYE THERAPEUTICS S.A. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about INEYE THERAPEUTICS S.A.'s valuation, stock price, and market status.
Is INEYE THERAPEUTICS S.A. a public or private company?
INEYE THERAPEUTICS S.A. is a private company.
What is the current stock price of INEYE THERAPEUTICS S.A.?
INEYE THERAPEUTICS S.A. is a private company, so its shares have no public market price. Caplight tracks INEYE THERAPEUTICS S.A.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is INEYE THERAPEUTICS S.A. worth (valuation)?
Valuation information for INEYE THERAPEUTICS S.A. is not publicly available.
Can I buy INEYE THERAPEUTICS S.A. stock?
INEYE THERAPEUTICS S.A. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was INEYE THERAPEUTICS S.A.'s last funding round?
INEYE THERAPEUTICS S.A.'s most recent funding round was VC Round on July 2, 2025.
Who are the main investors in INEYE THERAPEUTICS S.A.?
Key investors in INEYE THERAPEUTICS S.A. include Portugal Ventures.
Will INEYE THERAPEUTICS S.A. IPO soon?
No public IPO plans have been announced for INEYE THERAPEUTICS S.A..
How can I track INEYE THERAPEUTICS S.A. secondary market activity?
Caplight tracks bids, offers, and trades in INEYE THERAPEUTICS S.A.'s shares on secondary markets.